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Concerns about ionizing radiation during interventional cardiology have been increased in recent years as a result of rapid growth
in interventional procedure volumes and the high radiation doses associated with some procedures. Noncancer radiation risks
to cardiologists and medical staff in terms of radiation-induced cataracts and skin injuries for patients appear clear potential
consequences of interventional cardiology procedures, while radiation-induced potential risk of developing cardiovascular effects
remains less clear. This paper provides an overview of the evidence-based reviews of concerns about noncancer risks of radiation
exposure in interventional cardiology. Strategies commonly undertaken to reduce radiation doses to bothmedical staff and patients
during interventional cardiology procedures are discussed; optimisation of interventional cardiology procedures is highlighted.
1. Introduction
Medical exposure from X-rays and nuclear medicine is the
largest man-made source of radiation exposure, representing
amean effective dose of 1.0–3.0mSv per head per year [1].The
worldwide population exposure from medical radiation has
been shown to increase, and the use of procedures (both diag-
nostic and therapeutic) with a high radiation dose has been
growing steadily [2–5]. Although interventional cardiac pro-
cedures account for 12% of all radiological examinations, they
are responsible for delivering the highest radiation dose (up
to 50% of the total collective effective dose) [6]. Thus, radia-
tion exposure is a significant concern for interventional car-
diologists and patients due to the increasing workloads and
the complexity of procedures over the last decade [7, 8].
With fluoroscopy the patient is imaged in real time
to guide minimally invasive procedures that form part
of the diagnostic and interventional procedures, and this
requires medical and technical staff to directly participate in
the procedures. Patients undergoing interventional proce-
dures in cardiology face radiation exposure in the order of a
thousand or more times than that involved in conventional
radiography [9]. Similarly, the interventional cardiologists
encounter much more radiation than most other medical
staff due to their working position being close to the X-ray
beam and the patient (the source of scatter radiation).There-
fore, interventional cardiologists must have a thorough
knowledge of consequences of exposure to patients and
personnel to ionizing radiation andmethods of reducing staff
and patient radiation exposure. Evaluation and followup of
radiation doses received by the medical staff and patients
should be considered an important part of quality assurance
programmes for interventional cardiology procedures.
Radiation safety in the practice of interventional cardi-
ology has been addressed by several professional bodies. In
2005, theAmericanCollege ofCardiology (ACC) Foundation
proposed the interventional cardiology guidelines which
emphasized that physicians are responsible for minimizing
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the radiation injury hazard to their patients, professional staff,
and themselves [10]. The UNSCEAR 2008 report states that
fluoroscopic procedures represent the largest source of occu-
pational exposure in medicine [11]. In 2009, the American
Heart Association (AHA) Science Advisory recommended
the reference doses of common cardiology examinations [12],
and in 2010 the ACC committee also expressed the need
for appropriate and optimal use of radiation techniques in
cardiology [13].
This paper provides an overview of the radiation-induced
noncancer risks during interventional cardiology procedures,
with a focus on the radiation risks to interventional cardiolo-
gists and patients, as well as strategies commonly undertaken
to reduce radiation exposure.
2. Radiation-Induced Effects and Risks
to Interventional Cardiologists and Other
Medical Staff
There are two main biological effects of ionizing radiation:
stochastic effects, which include carcinogenic and genetic
effects and deterministic effects (also called tissue reactions),
which refer to an immediate and very predictable change
to the tissue [14]. Stochastic effects are those for which the
probability of an effect, rather than its severity, depends on the
dose of radiation received [15]. Radiation-induced cancer and
genetic effects are stochastic in nature and this has been well
addressed in the literature [16]. Stochastic effects are believed
not to have a dose threshold level because injury to a few
cells, or even a single cell could theoretically result in the
development of disease.
Deterministic effects occur when the dose exceeds a
specific threshold. The severity of deterministic effects com-
monly increases with dose, as more cells are killed or dam-
aged. Common examples of deterministic effects related to
interventional cardiology are skin and hair changes [17],
cataracts, and cardiovascular disease [18].
2.1. Radiation-Induced Cataracts. One of the most vital yet
ill-defined effects associated with ionizing radiation exposure
is the effect on the transparency of the eye lens, a pathology
called radiation cataract. According to their anatomic loca-
tion, cataract or presence of lens opacities can be classified
into three main types: nuclear, cortical, and posterior sub-
scapular [19]. Lens changes include small dots and vacuoles at
early stage of cataract, and these lesions aggregate to form
larger opacities at late stage of disease development. Although
the sensitivity of the lens of the eye to high doses of ionizing
radiation is well known, there exist uncertainties about the
relation between radiation dose and cataracts. The National
Council on Radiation Protection (NCRP) and the Inter-
national Commission on Radiological Protection (ICRP)
proposed guidelines on the view that cataractogenesis is
a deterministic effect and requires a threshold radiation
dose (currently 2Gy) [14, 20]. However, radiation-induced
cataracts are reported in populations exposed to much lower
doses than the current standards, and this strongly suggests a
stochastic hypothesis [21–23].
Occupational exposure to ionizing radiation and lens
opacities has been reported for medical personnel, such as
radiology technicians [24]. Earlier studies have demonstrated
a significant increase in eye lens opacities among interven-
tional cardiologists and medical staff in cardiac catheteriza-
tion laboratories [25, 26]. Later reports based on experiences
from different countries indicated that risk of lens opacities
among interventional cardiologists was at least twice that of
unexposed groups [27, 28].
In April 2011, the ICRP revised its lifetime eye dose
threshold for cataract induction downwards from 2000mSv
to 500mSv and the occupational annual dose limit from
150mSv to 20mSv in a year, averaged over defined periods
of 5 years, with no single year exceeding 50mSv [14, 29].
This recommendation is having an immediate impact on the
new International Basic Safety Standard issued by the Inter-
national Atomic Energy Agency (IAEA) and the upcoming
Directive of the EuropeanCommission [30, 31].The impact of
these new recommendations on the practice of international
cardiology is considered significant, since interventional car-
diologists are potentially at risk of developing radiation-
induced cataracts, depending on their level of exposure and
the number and complexity of invasive cardiac procedures
[32, 33].
Some epidemiological studies have been published on the
risk of cataracts in interventional cardiology. Junk et al. in
their first report consisting of 59 volunteer participants (radi-
ologists and cardiologists) observed that a high frequency of
37.3% participants having small paracentral dot-like opacities
in the posterior subcapsular regions of the lens, consistent
with early signs of radiation damage, and 8% had diagnosis
of cataracts [34]. This has been confirmed by a recent report
examining 54 cardiologists and 69 nurses and technicians,
with lens change found in 50% of interventional cardiologists
and 41% of nurses and technicians compared with findings of
similar lens changes in <10% of controls [35].
The Occupational Cataracts and Lens Opacities in Inter-
ventional Cardiology (O’CLOC) study represents a large scale
epidemiological study with the aim of testing the existence of
an increased risk of radiation-induced cataracts among inter-
ventional cardiologists compared with a control group of car-
diologists not exposed to X-rays [33, 36]. Unlike these earlier
studies, the O’CLOC study included 106 interventional cardi-
ologists (including coronary interventional cardiologists and
electrophysiologists) and 99 unexposed nonmedical workers.
The study showed a significant excess risk of cataract for inter-
ventional cardiologists: 18% of posterior subcapsular lens
opacities among interventional cardiologists were observed,
while only 5% among control group were observed (𝑃 <
0.05). Regarding cumulative eye lens dose, results were con-
sistent with this excess risk. Overall, 29%of the interventional
cardiologists and 20% of the electrophysiologists had a
cumulative dose exceeding 500mSv. These findings indicate
that according to the revised ICRP lifetime eye dose threshold
of 500mSv, >25% of these cardiologists may already at risk of
developing early radiation-induced cataracts. Furthermore,
electrophysiologists may have had higher annual doses than
cardiologists in recent years due to less use of eye protection
equipment. These findings reinforce those reports based on
BioMed Research International 3
small sample sizes and highlight the importance of increasing
cardiologists’ awareness of the regular use of radiation protec-
tion devices and the necessity of optimizing procedures for
dose reduction.
The Optimization of RAdiation protection for MEDical
staff (ORAMED) project is funded by EU-EURATOMwithin
the 7∘ Framework Programme with the aim of studying the
dose received by operators in some selected practices of diag-
nostic and interventional radiology and nuclear medicine
procedures [37, 38]. The WP1 (working package) of the
project is devoted to studying the eye lens and extremity doses
in interventional radiology and cardiology. Early results of
the ORAMED project showed that the highest eye lens doses
were measured during embolization procedures [37]. With
increasing workload and complexity of the interventional
cardiology procedures, the annual eye lens doses would be
estimated to be relatively higher or even exceed the dose
limits.
In summary, there is evidence of radiation-induced cata-
ract risk at lower doses than previously realised and following
protracted exposure. Although studies provide additional
evidence for radiation causing damage to the eye, even at low
doses, most studies in the literature do not allow assessment
of the clinical impact of the radiation associated opacities
[29]. Ionizing radiation exposure has been identified to link
to vision-impairing cataracts in the A-bomb survivors in a
recent study [39], although further research is needed to focus
on interventional cardiologists regarding radiation exposure
and development of cataracts.
2.2. Radiation-Related Cardiovascular Diseases. Increased
risk of cardiovascular diseases associated with ionizing radi-
ation has received recent attention. Several studies have
demonstrated the effects of ionizing radiation on hematologic
parameters and immunologic function [40]; however, the
question of whether radiation affects other physiologic phe-
nomena, including arterial blood pressure, is still under
debate despite continuous research efforts [41–43]. The key
elements in radiation damage to vessels (microvessels in par-
ticular) are the endothelial cells [44]; however, much remains
to be known about the intimate mechanisms of relationship
between ionizing radiation and the endothelium damage.
Experimental and human observations suggest that the
endothelial cells are the most radioresponsive cells in the
mesenchyma [45].The initial response appears to be endothe-
lial cell damage, leading to monocyte adhesion and trans-
migration into the subendothelial space. In the presence
of elevated cholesterol levels, these invading monocytes
transform into activated macrophages, which contribute to
the formation of fatty streaks in the intima, resulting in the
cascade of pathogenic changes that lead to radiation related
heart disease [46–49]. Russo et al. analysed the response to
chronic low-dose radiation by comparing 10 healthy inter-
ventional cardiologists with 10 unexposed controls by mea-
suring hematological changes of redox state in lymphocytes
[50]. The findings of their study demonstrate the association
between low dose radiation and an altered redox balance
which is manifested by an increase in hydrogen peroxide
and adaptive cellular responses, although clinical meaning
remains to be understood.
Early studies suggest that low-dose radiation can make
human lymphocytes less susceptible to the genetic damage
manifested as chromatic breakage induced by a subsequent
high dose of X-rays [51, 52]. Latermortality analysis of atomic
bomb survivors shows that radiation exposure increases car-
diovascular disease mortality, suggesting that ionizing radi-
ation accelerates blood vessel degeneration [53]. Increased
mortality risk was reported for heart disease, stroke, and res-
piratory diseases in the Life Span Study of atomic bomb sur-
vivors, with an excess relative risk for death fromheart disease
of 0.14 per sievert [54]. Dose above 0.5Gy was found to be
associated with an elevated risk of both stroke and heart dis-
ease [55].
Epidemiological data on low dose radiation-induced
damage to cardiovascular system are scare and conflicting: an
increased cardiovascular disease risk was reported from stud-
ies of early radiologists in USA [56] but not from radiologists
in the UK [57]. Studies of radiologists and radiologic tech-
nologists in the USA [58], Canada [59], Japan [60], Denmark
[61], and China [62] lacked individual doses. Hauptmann
et al. reported excess mortality from cardiovascular system
based on their data on the US radiologic technologists [58],
while other studies have not provided detailed analyses of
cardiovascular disease. Their results showed that, for deaths
from ischemic heart disease based on an analysis of 633
radiologic technologists, the relative risks were 0.98, 1.00, and
1.22 during 1950–1959, 1940–1949, or before 1940, compared
with 1960 or later.
Although mortality from cardiovascular diseases
increased with radiation dose among atomic bomb survi-
vors, other epidemiological data investigating the association
between low doses of ionizing radiation and circulatory
diseases have not provided clear evidence of such a relation-
ship. Yamada et al. in their cross-sectional analysis of atomic
bomb survivors found that aortic calcification increases with
radiation dose, thus, suggesting linkage between low-dose
radiation dose and atherosclerotic cardiovascular changes.
Prevalence of mild aortic arch calcification was found in
26.2% for men and 31.9% for women. There is a significant
correlation between aortic calcification and radiation
dose with dose more than 0.5Gy resulting in significantly
higher percentage of severe calcification when compared
to the dose value of less than 0.5Gy [63]. This is consistent
with the dose limits of 0.5 Gy provided by ICRP [14]. Thus,
medical professionals should be aware that the absorbed dose
threshold for cardiovascular diseasemight be as low as 0.5Gy
to the heart.
A longitudinal study of the relationship atomic bomb
exposure and cardiovascular disease in the Adult Health
Study (AHS) has shown dose related increases in the inci-
dence of stroke and myocardial infarction and in the inci-
dence or prevalence of hypertension, elevated cholesterol
levels in the exposed subjects [64–67]. The findings of the
epidemiological study of cardiovascular disease have been
further confirmed by a recently published study conducted
by Shimizu et al. withmore than 50 years of followup of 86611
atomic bomb survivors [68].The study provides the strongest
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evidence so far that radiation dose may increase the preva-
lence of stroke and heart disease at moderate dose levels
(mainly 0.5–2Gy), although robust confirmatory evidence
from other studies is needed.
In summary, data on the association between chronic
low dose radiation and cardiovascular diseases are currently
limited. Epidemiological studies are needed to help clarify
the possible mechanisms between radiation exposure and its
effect on the microcardiovascular damage.
3. Radiation-Induced Risks to Patients
Interventional cardiology procedures such as coronary angi-
ography, percutaneous transluminal coronary angioplasty
(PTCA), radiofrequency ablation, electrophysiological study,
and left ventriculography contribute a significant proportion
of radiation dose to patients due to the long fluoroscopy times
and high-quality images required. Radiation doses can vary
substantially across the same cardiac angiographic and inter-
ventional procedures, which is often a result of varying com-
plexities of examination or patient size but can be a conse-
quence of technological or procedural preference.
Patient dosimetry methods and quantities currently used
in interventional cardiology can be divided into three cate-
gories [69]: (1) dosimetry for stochastic risk evaluation, which
is associated with the risk of cancer induction; (2) dosimetry
for quality assurance, which addresses evaluation of the
optimization level of interventional cardiology procedures in
comparison with performance of equipment and operator
skill or comparison of the practice among different clinical
centres; (3) dosimetry for deterministic effects of radiation
exposure, which is related to the risk of deterministic injuries
occurring. Dose quantities such as DAP (dose area product),
fluoroscopy time, cine time, and number of cine images
are useful indicators for evaluation of optimization level of
interventional procedures [69, 70]. Effective dose is the most
commonly used indicator in the assessment of diagnostic
practice as it allows for estimation of the health risk due to
stochastic effects of radiation.
3.1. Patient Dose. The radiation exposure to patients is deter-
mined by many factors, such as the X-ray equipment perfor-
mance, the protocol used (e.g., frequency of cine frames, tube
angulation, and the level of image quality), the operator skill
and experience, the patient size, the interventional approach
(e.g., femoral or radial technique), and several parameters
related to the complexity and the nature of the intervention
[71–74]. The Council Directive of the European Community
97/43 Euratom (MED) deals with the health protection
of patients against risks of ionizing radiation associated
with medical procedures and focuses on special procedures
including interventional radiology [75]. Dose reference levels
developed at the European level can be recommended in
interventional cardiology examinations.
Delichas et al. found that the radiation dose to the patient
is influenced by the individual characteristics of each inter-
ventional procedure [76]. The maximal annual dose values
received by 9 cardiologists during 144 cardiac procedures
in two hospitals in their study were found to be 1.9 and
2.8mSv, which are much higher than the reference levels
defined by the European DIMOND approach [77]. Tsapaki
et al. reported differences of radiation exposure to patients
between cardiologists with various levels of experience.Their
results showed that the mean DAP values for coronary
angiography and PTCA were 34.3 Gy × cm2 and 55.3Gy ×
cm2 for cardiologists with more than 10 years of experience
[78], while for cardiologists with less than 5 years of expe-
rience, the corresponding DAP values were 48.8Gy × cm2
and 89.2Gy × cm2, respectively. Bernardi et al. in their survey
showed the correlation between radiation dose and types of
interventional cardiology procedures with mean DAP being
65.8Gy × cm2, 93Gy × cm2, and 116.7 Gy × cm2, correspond-
ing to the simple, medium, and complex procedure groups
[79]. These reports emphasize the importance of minimizing
radiation dose to patients during interventional cardiology
procedures by taking into account the operator’s experience
and complexity of the procedures.
In summary, patient radiation dose varies widely not only
among different interventional cardiology procedures but
also among published studies. Discrepancies of the available
results in the literature are patient-, procedure-, cardiologist-,
and fluoroscopic equipment-related. Interventional cardiol-
ogy procedures can expose patients to high radiation doses,
thus, efforts to minimize patient exposure should always be
undertaken.
3.2. Radiation-Induced Skin Injury. Skin is the organ at
greatest risk during complex interventional procedures. Skin
changes such as erythema, ulcers, telangiectasia, and dermal
atrophy are well-known deterministic effects of ionizing
radiation [80–82]. Although commonly referred to as skin
injuries, severe radiation injuries can extend into the sub-
cutaneous fat and muscle [83]. Patients may face years of
associated pain,multiple surgical procedures, and permanent
disfigurement [17, 84]. An early response (early transient
ischemia) is noticed a few hours after doses of >2Gy, when
the exposed area is relatively large [14]. An actual skin dose
in the 5–10Gy range will always produce a noticeable injury
with doses above 15Gy leading to tissue being destroyed to a
depth of a few centimetres and dermal necrosis [14, 85]. To
minimize this risk, evaluation and assessment of maximum
skin dose in interventional cardiology procedures are of
paramount importance and should be recommended in the
daily practice, although it is very difficult to undertake [86,
87].
Case reports describing deterministic radiation injuries
on patient skin are increasing in the literature, and the poten-
tial for deterministic effects in some instancesmay be ofmore
concern than stochastic long-term risk. Padovani and col-
leagues reported that the frequency of skin injuries in patients
undergoing interventional cardiac procedures was less than
0.03% [70]. Kato et al. in their recent study observed 1.5% of
radiation skin injury in 400 consecutive interventional car-
diac procedures [88]. The higher rate of radiation injury in
Kato’s studymay be due to the inclusion of many complicated
interventional procedures, which result in high radiation
doses exceeding the safe threshold level for skin. Radiation
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injuries are often misdiagnosed due to the late occurrence of
their signs and symptoms, usually weeks after interventional
procedures. Major injuries continue to progress for many
months after the procedure. In most cases skin injuries have
been reported in relationship with not optimised or improper
use of radiological equipment due to the lack of knowledge of
interventional cardiologists of radiological image formation,
radiology technology, and radiation protection rules. It is a
legal requirement to report significant radiological incidents
and accidents that during or as a direct result of using ionizing
radiation for a medical procedure. However, in practice, such
reporting system is hardly implemented in many countries.
The IAEA has set up its own international reporting
system called SAFety in RADiological procedures (SAFRAD)
which is anonymous, so that it can be used for dose mon-
itoring and reporting [89]. The reporting system includes
patients who are exposed to defined trigger levels or events
in fluoroscopically guided diagnostic and interventional pro-
cedures in an international database. The Safety in Radiation
Oncology (SAFRON) is in the process of being developed by
the IAEA to compile reports of medical radiation “incidents”
that put patients at risk [90], and the IAEA smart card project
on SmartRad Track makes tracking patient exposure a reality
[91].
Development of online methods, based on calculation of
skin dose distribution on the patient’s skin, could be useful
to alert the cardiologists when the regional skin dose exceeds
the threshold for deterministic injuries [92]. Balter andMoses
introduced a dose managing program in interventional
cardiology [85]. This program uses a significant dose (refer-
ence point dose of 5Gy for coronary procedures) as an action
trigger for additional documentation and followup, which
is designed to set low enough dose value to minimize the
probability of missing a clinical deterministic injury. Simi-
larly, Faulkner et al. proposed trigger levels for different inter-
ventional cardiology procedures based on different field sizes
(DAP trigger level ranges from 20 to 400Gy × cm2 corre-
sponding to field size from 10 to 200 cm2), whichmay be used
to identify patients at the risk of deterministic injuries [93].
In summary, radiation injury to human skin occurs at
actual skin doses as low as a few gray.The dose-response rela-
tionships for both early and late radiation-induced damage
to the skin are significantly influenced by the exposure rate.
Increasing the dose above the injury threshold increases the
degree of injury and prolongs the healing process.
4. Strategies to Reduce Radiation Risks to
Interventional Cardiologists and Patients
Radiation exposure of interventional cardiologists and
patients is currently a major concern. The National Council
on Radiation Protection and Measurements recommends
intraprocedure announcements of air-kerma to occur at
1000mGy increments starting at 3000mGy and recommends
that specific postprocedure management practices are imple-
mented following procedures with considerable radiation
dose levels>5000mGy [94]. Cardiac patients are increasingly
exposed to cumulative diagnostic and therapeutic techniques
of cardiac imaging using ionizing radiation, such as coronary
angiography (average effective dose 5–10mSv), PTCA (7–
20mSv), and nuclear cardiology (6–15mSv) [95].
Patient and staff dosimetry on paediatric interventional
cardiology procedures is another issue as cardiologists gen-
erally need to stay closer to the patient in comparison with
adult procedures [96]. A prominent feature in paediatric flu-
oroscopy and intervention is the large size of the image inten-
sifiers relative to the size of the neonate, infant, or child. The
image intensifier will completely cover the patient and there-
fore has the potential to increase radiation exposure if colli-
mation is not used [97]. Reports involving the evaluation of
paediatric cardiology procedures are limited. Ubeda et al. in
their multicentre study indicated the large variability in
paediatric interventional cardiology protocols and imaging
parameters (including kV andmA ranges for fluoroscopy and
cine modes), with measured scatter dose ranging from 0.8 to
12mSv h−1 at the eye position during fluoroscopy and cine
modes if no protective tools are used [96].
Several aspects of radiation safety in the interventional
cardiology have been proposed with effective dose reduction
outcomes having been achieved. These include strategies of
dose monitoring during the procedure, wearing protective
devices, applying dose-reduction techniques, and imple-
menting training and education programmes.
4.1. Dose Monitoring. It is necessary for interventional cardi-
ologists to wear dosimeters on a regular basis. Occupational
dosimetry is critical for the personal safety of interventional
cardiologists. The ICRP and ACC recommend the use of two
personal dosimeters, with one worn outside the apron at the
shoulder or neck and the other worn under the apron at the
waist [6, 98]. In addition, special dosimeters could be used
for special practices (e.g., a ring dosimeter for biliary drain-
age/stent procedure which involves delivery of high doses to
the hands) to monitor doses to the skin, hands, feet, and the
lens of eyes.
Martin conducted a review of the dose data from studies
of radiology performed over the last 20 years which involved
X-ray procedures by radiology, cardiology, and othermedical
staff [99]. The doses in the studies reviewed vary by factors
of 60–100 for similar procedures in different centres. As the
number of interventional procedures is gradually increasing
and the potential for medical staff to receive high doses, it
is important to ensure that doses received by interventional
cardiologists are monitored to check whether the protection
devices are deployed effectively.
4.2. Use Protective Shielding and Wear Protective Devices.
Equipment-mounted shielding includes protective drapes
suspended from the table and from the ceiling. Ceiling-sus-
pected shields can provide substantial dose reduction, espe-
cially to the unprotected areas such as head and neck. Under-
table lead drapes reduce lower extremity dose substantially
and should be used whenever possible [100]. They should
always be employed, as they have been reported to signifi-
cantly reduce operator dose [101].
It has been reported that interventional cardiologists
received an average annual effective dose of 46.2mSv without









Figure 1: Wearing protective devices during interventional cardiol-
ogy procedures.
wearing protective devices [102]. The dose can be reduced to
3.5mSv per year using a lead apron and to 1.7mSv per year
using both a lead apron and a thyroid shield (Figure 1) [103].
Whereas the effective dose is routinely assessed by dosimetry,
less attention is given to the local scatter radiation doses to
unprotected parts of the body, especially the head and hands
as cardiologists are also exposed to scatter radiation. Thus,
wearing protective devices should be highly recommended
during interventional cardiology procedures.
In cardiac intervention, radiation shields are widely used
to reduce scatter radiation; however, the use of protective
shields plays an essential role in optimizing protection during
the interventional cardiology procedures (Figure 2). Fetterly
et al. in their study reported that radiation shields must be
thoughtfully placed and actively managed both before and
during the procedure to be effective in providing substantial
protection from radiation during interventional cardiology
procedures [104]. Best practice guidelines for shield use are
provided in their study with regard to upper body protection,
lower body shields, or different approaches relating to differ-
ent interventional procedures.
A leaded glass or plastic screen placed between the patient
and the operator protects the operator’s eyes, head, and neck.
Leaded eye glasses with protective side shields provide more
protection than eye glasses without these features [105]. Prop-
erly placed shields have been shown to reduce operator eye
dose significantly [106, 107]. These screens add no weight to
the operator, eliminating the ergonomic consequences of the
protective equipment; thus they can effectively replace both
leaded eyewear [7]. Maeder et al. reported the effectiveness
of reduction of scatter radiation to the eyes with use of a
transparent lead glass screen, but minimal effects on the dose
to the hands [106]. Therefore, additional efforts are required
to reduce dose levels to both patients and operators.
The X-ray tube close to operator and
without shield protecting the operator
(a)
The X-ray tube close to operator and
with shield protecting the operator
(b)
Figure 2: (a) The lateral projection is not recommended when the
lead shield is not protecting the operator. (b) The lateral projection
is recommended when the lead shield is protecting the operator.
4.3. Education and Training Programmes. It is important for
the medical profession and other healthcare professionals to
be aware of the hazards from radiation in order to avoid the
unnecessary risks to the population as a whole. Lack of know-
ledgemay result inmore ionizing radiation imaging examina-
tions being requested when other nonradiation tests could be
performed or when different lower-dose imaging tests could
be performed. This is particularly important for interven-
tional cardiology procedures as they deliver high doses to
medical staff and patients. As such, the need for education
and training in radiological protection is more compelling.
The European Commission and ICRP have addressed the
importance of training in radiological protection, publishing
guidelines with specific recommendations for accreditation
of training programmes for interventional procedures [108,
109]. ICRP Publication 113 recommends that training in
radiological protection is included in the quality assurance
programme, with special attention to training given to fellows
and residents [109]. The guideline provided by European
Commission suggests specific learning objectives and 20–30
hours of training for interventional cardiologists.Much effort
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Table 1: Dose reduction techniques that are commonly used in interventional cardiology procedures.
Techniques used in interventional cardiology Corresponding functions
Minimize use of fluoroscopy time and use low fluoroscopy mode Reduce staff and patient dose
Number of fluorographic images Reduce staff and patient dose
Image-chain geometry Reduce patient dose
Collimation of the radiation field Decrease the level of scatter dose
Medical staff position in a low-scatter area Reduce staff dose
Wear protective shielding Reduce radiation dose to eye lens and other organs
Fluoroscopic imaging equipment comply with International
Electrotechnical Commission [119] Dose-reduction technology is incorporated into the imaging systems
Obtain appropriate training provided by professional bodies Increase awareness of radiation protection and dose reduction
Wear personal dosimeter Know and monitor your own dose
Diagnostic reference levels Monitor clinical practice and radiation dose
has beenmade over the last decade to produce trainingmate-
rials to help improvement of radiation protection in inter-
ventional cardiology procedures, with successful outcomes
having been achieved [85, 95, 110]. The educational pro-
gramme has been shown to be effective at improving compli-
ance with the radiation badge monitoring programme [111].
Cardiology scientific societies should promote training activ-
ities in radiation protection to maintain a high level of radia-
tion safety in the practice of interventional cardiology. The
Guidance Document developed as work package 3 of the
MEDRAPET project is expected to be used as the basis for
curricula of radiation protection courses [112].
There is an urgent need to implement and propagate
widely the training programs in interventional cardiology
such as the IAEA initiated radiation cataract study called
Retrospective Evaluation of Lens Injuries and Dose (RELID),
which is organized in collaboration with professional soci-
eties of cardiologists in many countries [113].
4.4. Dose Reduction Techniques. Operational measures play
an important role in improving radiation protection and
dose reduction to bothmedical staff and patients. Decreasing
patient dose will result in a proportional decrease in scatter
dose to the operator; therefore, techniques that reduce patient
dose will generally reduce occupational dose. A practical
advice to reduce orminimize the occupational radiation dose
has been recently proposed by the Cardiovascular and Inter-
ventional Society of Europe (CIRSE) [101]. Table 1 sum-
marises various dose-reduction techniques and the corre-
sponding functions.
One of themost important radiation protectionmeasures
is to increase patient’s distance from the radiation source.
Working at 80 cm from the isocenter instead of 40 cm can
decrease scattered dose to approximately 25% of the original
dose [114]. Variable dose values associated with radial versus
femoral artery access have been reported in the literature
[115, 116]. Fetterly et al. demonstrated that patient dose was
reduced simultaneously with increased utilization of radial
access [104]. Other technical alterations provide the potential
for systematic dose reduction, including a change from con-
tinuous fluoroscopy to pulsed fluoroscopy modes; reduction
in fluoroscopy/acquisition frame rate from 30 frames/s to
7.5/15 frames/s; collimation of the radiation field to decrease
the level of scattered dose; improved X-ray image detection
anddisplay systems; and increased use ofmetallic X-ray beam
spectral filters for both fluoroscopy and acquisition imaging
[104, 114]. Improved image processingwithin the fluoroscopic
unit can compensate to a greater extent for the reduced image
quality due to decreased exposure levels.
Diagnostic reference levels (DRLs) are radiation dose val-
ues for specific examinations that should not be consistently
exceeded when good practice is in place and if regularly
exceeded remedial action should be sought. DRLs are used
to help avoid radiation dose to the patient that does not
contribute to the medical imaging task. They are intended to
provide guidance on what is achievable with current good
practice rather than optimum performance and help to
identify unusually high radiation doses or exposure levels
[7].These are legal requirements in a number of jurisdictions
[117, 118] and have been shown to be very effective in reducing
dose and dose variations for a variety of investigations since
their introduction two decades ago.
5. Summary and Conclusion
In recent years, intensive efforts have been initiated to reduce
the radiation dose associated with interventional cardiology.
It has been become a routine practice for publications
addressing cardiac intervention to report radiation doses.
There is increasing concern about the potential deleterious
effects from radiation arising from intervention cardiology
due to two reasons: first, cardiac procedure volumes have
grown tremendously. Second, the radiation doses received by
interventional cardiologists and patients can vary by more
than an order of magnitude for the same type of procedure.
Increased workload, complexity of the interventional proce-
dures, and acute patient conditions contribute significantly to
the amount of radiation exposure to both patients and med-
ical staff.
Noncancer risks of radiation in interventional cardiology
that have been discussed in different scenarios empha-
size the importance of reducing radiation dose to patients
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and medical staff. This can be achieved through implement-
ing necessary strategies such as continual improvements in
protocols and equipment, implementation of guidelines pro-
posed by professional bodies into daily practice and attending
training programmes to ensure best practice. Epidemiolog-
ical studies involving a large cohort of individuals exposed
to ionizing radiation will provide us with a full picture as
to the true effects of radiation exposure from interventional
cardiology. A final general recommendation is that being
aware of the radiological protection of your patient will also
be improving your own occupational protection.
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